The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands
Colorectal Disease · 2025
DOI: 10.1111/codi.70054 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Colorectal Disease, 2025. Verfasst von Aaya Darai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Rectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aim
Treatment of rectal cancer has improved significantly over the past decades. However, the role of adjuvant chemotherapy remains a matter of debate. The aim of this study is to evaluate the association between adjuvant chemotherapy and overall survival of patients with rectal cancer.
Method
Data from the Netherlands Cancer Registry were used to evaluate all nonmetastatic pathological node‐positive patients who underwent treatment for rectal cancer during the time period 2009–2020 in the Netherlands. Patients were grouped according to whether they received adjuvant chemotherapy. Patients were further divided into three groups according to the type of preoperative treatment. Propensity score matching (PSM) was applied based on patient‐related variables, tumour‐related variables and treatment‐related variables. The matching procedure for PSM was done with nearest neighbour and without replacement employing a 1:1 ratio. Kaplan–Meier analysis was performed after PSM to compare overall survival.
Results
A total of 7479 patients were included, of whom 865 (11.6%) underwent adjuvant chemotherapy. After PSM the no neoadjuvant treatment group included 240 patients per study arm, the neoadjuvant radiotherapy group 317 and the neoadjuvant chemoradiation group 182 patients. A significant difference in 5‐year survival was found comparing adjuvant versus no adjuvant chemotherapy in all subgroups: no neoadjuvant treatment 54.6% vs. 40.8% ( p = 0.003), neoadjuvant radiotherapy 77.0% vs. 53.9% ( p < 0.001) and neoadjuvant chemoradiation 68.1% vs. 45.6% ( p < 0.001).
Conclusion
Adjuvant chemotherapy was associated with an improved 5‐year survival in all subgroups. The role of adjuvant chemotherapy in the treatment of rectal cancer should be reconsidered in node‐positive patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands.
- Department of Surgery, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
- Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
- Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands.
- Department of Oncology, Elisabeth TweeSteden Hospital, Tilburg, The Netherlands.
- Department of Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
ORCID-Profile: Aaya Darai, Tijmen Koëter, David D E Zimmerman
Zitieren
APA
Darai, A., Koëter, T., van Erning, F. N., van Alphen, R. J., Verheul, H. M. W., Verheij, M., Zimmerman, D. D. E., Vissers, P. A. J., & de Wilt, J. H. W. (2025). The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands. Colorectal Disease. https://doi.org/10.1111/codi.70054
Vancouver
Darai A, Koëter T, van Erning FN, van Alphen RJ, Verheul HMW, Verheij M, et al. The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands. Colorectal Disease. 2025. doi:10.1111/codi.70054
BibTeX
@article{Darai2025,
author = {Darai, Aaya and Koëter, Tijmen and van Erning, Felice N and van Alphen, Robbert J and Verheul, Henk M W and Verheij, Marcel and Zimmerman, David D E and Vissers, Pauline A J and de Wilt, Johannes H W},
title = {The role of adjuvant chemotherapy in rectal cancer: A nationwide cohort study from the Netherlands},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70054}
}
EUVIMED